Market Closed -
OTC Markets
03:22:13 2024-07-10 pm EDT
|
5-day change
|
1st Jan Change
|
0.25
USD
|
-21.88%
|
|
-16.67%
|
+177.78%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2.154
|
0.172
|
3.039
|
6.392
|
1.528
|
0.8762
|
Enterprise Value (EV)
1 |
2.593
|
0.4901
|
3.575
|
7.404
|
3.028
|
2.606
|
P/E ratio
|
-55.8
x
|
-1.56
x
|
-8.77
x
|
-7.45
x
|
-1.48
x
|
-1.81
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
24,399,721
x
|
4,519,126
x
|
1,228,893
x
|
621,858
x
|
EV / Revenue
|
-
|
-
|
28,709,143
x
|
5,234,663
x
|
2,435,468
x
|
1,849,662
x
|
EV / EBITDA
|
-
|
-
|
-
|
-15,881,564
x
|
-6,198,961
x
|
-15,508,548
x
|
EV / FCF
|
-
|
-2,718,988
x
|
-34,197,454
x
|
-27,850,670
x
|
-257,132,909
x
|
146,306,911
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
-4.04
x
|
-0.64
x
|
-4.99
x
|
7.76
x
|
20.1
x
|
-2.33
x
|
Nbr of stocks (in thousands)
|
3,590
|
3,590
|
6,563
|
8,756
|
9,316
|
9,736
|
Reference price
2 |
0.6000
|
0.0479
|
0.4630
|
0.7300
|
0.1640
|
0.0900
|
Announcement Date
|
3/28/19
|
2/21/20
|
3/11/21
|
4/1/22
|
3/29/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
0.1245
|
1.414
|
1.243
|
1.409
|
EBITDA
|
-
|
-
|
-
|
-0.4662
|
-0.4884
|
-0.168
|
EBIT
1 |
-0.0274
|
-0.1541
|
-0.2751
|
-0.5023
|
-0.5605
|
-0.2402
|
Operating Margin
|
-
|
-
|
-220.91%
|
-35.51%
|
-45.09%
|
-17.04%
|
Earnings before Tax (EBT)
1 |
-0.0386
|
-0.1665
|
-0.3274
|
-0.7702
|
-0.996
|
-0.4684
|
Net income
1 |
-0.0386
|
-0.1665
|
-0.3274
|
-0.7702
|
-0.996
|
-0.4684
|
Net margin
|
-
|
-
|
-262.89%
|
-54.45%
|
-80.12%
|
-33.24%
|
EPS
2 |
-0.0108
|
-0.0308
|
-0.0528
|
-0.0980
|
-0.1107
|
-0.0497
|
Free Cash Flow
|
-
|
-0.1802
|
-0.1045
|
-0.2658
|
-0.0118
|
0.0178
|
FCF margin
|
-
|
-
|
-83.95%
|
-18.8%
|
-0.95%
|
1.26%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/19
|
2/21/20
|
3/11/21
|
4/1/22
|
3/29/23
|
3/27/24
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
0.33
|
0.3553
|
0.3508
|
0.2693
|
0.2677
|
0.3528
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.0632
|
-0.0141
|
-0.0737
|
-0.2034
|
-0.1277
|
-0.1027
|
Operating Margin
|
-19.14%
|
-3.97%
|
-21%
|
-75.53%
|
-47.69%
|
-29.12%
|
Earnings before Tax (EBT)
1 |
-0.2704
|
-0.1903
|
-0.2794
|
-0.3101
|
-0.2162
|
-0.1926
|
Net income
1 |
-0.2704
|
-0.1903
|
-0.2794
|
-0.3101
|
-0.2162
|
-0.1926
|
Net margin
|
-81.94%
|
-53.56%
|
-79.64%
|
-115.15%
|
-80.76%
|
-54.58%
|
EPS
2 |
-0.0300
|
-0.0200
|
-0.0300
|
-0.0300
|
-0.0200
|
-0.0200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/1/22
|
5/16/22
|
8/15/22
|
11/14/22
|
3/29/23
|
5/12/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.44
|
0.32
|
0.54
|
1.01
|
1.5
|
1.73
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-2.171
x
|
-3.071
x
|
-10.29
x
|
Free Cash Flow
|
-
|
-0.18
|
-0.1
|
-0.27
|
-0.01
|
0.02
|
ROE (net income / shareholders' equity)
|
7.51%
|
34.6%
|
63.1%
|
-714%
|
-221%
|
313%
|
ROA (Net income/ Total Assets)
|
-
|
-686%
|
-106%
|
-25%
|
-16.8%
|
-8.25%
|
Assets
1 |
-
|
0.0243
|
0.3087
|
3.075
|
5.922
|
5.677
|
Book Value Per Share
2 |
-0.1500
|
-0.0700
|
-0.0900
|
0.0900
|
0.0100
|
-0.0400
|
Cash Flow per Share
|
-
|
0
|
0.0100
|
0.0300
|
0.0200
|
0.0100
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/19
|
2/21/20
|
3/11/21
|
4/1/22
|
3/29/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| +177.78% | 2.55M | | +17.30% | 82.59B | | -26.28% | 72.22B | | -1.34% | 26.41B | | +4.17% | 17.69B | | -9.26% | 16.89B | | +4.08% | 15.6B | | +76.90% | 13.7B | | +76.96% | 12.77B | | -25.96% | 12.76B |
Other Healthcare Facilities & Services
|